In this article Drug Target Review’s Izzy Wood shares some of the latest findings revealed using CRISPR that could be used in the development or design of new therapies.

Join our webinar to hear from industry experts as they discuss a variety of topics. Hear about advances toward precision medicine through the use of cutting-edge methods and analysing critical patient immune data in response to therapies and disease progression.

US researchers have tested mRNA-based vaccine against influenza viruses, with promising results in animal models, that pave the way for clinical trials.

Swedish researchers have designed synthetic DNA that controls a cells’ protein production using AI.

US researcher from the University of Houston is the first to report a novel cell therapy process for heart regeneration, that conducts electricity throughout the heart to enable rhythmic heartbeat and repair diseased hearts.

Researchers have identified a protein that, when present in high amounts in breast cancer tumours, is an indicator of whether DNA-damaging therapies will work or not.

US scientists have developed a potential medication for the genetic cause of ALS and dementia, that eliminates the mutated segments of RNA.

US researchers unmask the consequences of treating adolescent acne with systemic antibiotics; as it can lead to altered profiles of circulating bile acids that reduce osteoblast function and bone mass accrual.